|
OMIM |
Link |
Information gain |
01 |
|
fanconi renotubular syndrome
|
[NCBI]
|
0.00215938
|
|
|
NPPA
|
[NCBI]
|
0.0017683
|
|
|
PTH
|
[NCBI]
|
0.00166155
|
|
|
pseudohypoparathyroidism, type ii
|
[NCBI]
|
0.0014207
|
|
|
AVP
|
[NCBI]
|
0.00107436
|
|
|
iminoglycinuria
|
[NCBI]
|
0.000844761
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
0.000550055
|
|
|
polycystic kidneys
|
[NCBI]
|
0.000405116
|
|
|
renal tubular acidosis, proximal, with ocular abnormalities and mental retardation
|
[NCBI]
|
0.000202328
|
|
|
SLE
|
[NCBI]
|
0.000187948
|
|
|
renal tubular acidosis, distal, autosomal dominant
|
[NCBI]
|
0.000169611
|
|
|
HFTC
|
[NCBI]
|
0.000154928
|
|
|
dent disease 1
|
[NCBI]
|
0.000151976
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
0.000137809
|
|
|
renal tubular acidosis, proximal
|
[NCBI]
|
0.000134721
|
|
|
renal tubular acidosis iii
|
[NCBI]
|
0.000134721
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
0.000134035
|
|
|
HNFJ
|
[NCBI]
|
0.00012898
|
|
|
hypomagnesemia, renal, with ocular involvement
|
[NCBI]
|
0.000106971
|
|
|
NPS
|
[NCBI]
|
0.000105037
|
|
|
hypouricemia, familial renal, due to tubular hypersecretion
|
[NCBI]
|
9.65122e-05
|
|
|
LPI
|
[NCBI]
|
9.28368e-05
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
8.09108e-05
|
|
|
HOMG3
|
[NCBI]
|
7.73492e-05
|
|
|
NPHP2
|
[NCBI]
|
7.45012e-05
|
|
|
renal cysts and diabetes syndrome
|
[NCBI]
|
6.60248e-05
|
|
|
PG
|
[NCBI]
|
6.54845e-05
|
|
|
NPHS1
|
[NCBI]
|
6.41559e-05
|
|
|
OPTB3
|
[NCBI]
|
5.89085e-05
|
|
|
NT5E
|
[NCBI]
|
5.75977e-05
|
|
|
NPHP1
|
[NCBI]
|
5.66636e-05
|
|
|
EPO
|
[NCBI]
|
5.2803e-05
|
|
|
OCRL
|
[NCBI]
|
5.11784e-05
|
|
|
TNF
|
[NCBI]
|
5.05587e-05
|
|
|
ALMS
|
[NCBI]
|
5.04008e-05
|
|
|
cystinuria
|
[NCBI]
|
4.63105e-05
|
|
|
aHUS
|
[NCBI]
|
4.29609e-05
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
4.19678e-05
|
|
|
ARPKD
|
[NCBI]
|
3.69402e-05
|
|
|
VEGF
|
[NCBI]
|
3.42964e-05
|
|
|
SLC22A6
|
[NCBI]
|
3.06832e-05
|
|
|
SPINK1
|
[NCBI]
|
2.80912e-05
|
|
|
MAS
|
[NCBI]
|
2.78103e-05
|
|
|
ADM
|
[NCBI]
|
2.69906e-05
|
|
|
fabry disease
|
[NCBI]
|
2.67784e-05
|
|
|
KIRREL
|
[NCBI]
|
2.56915e-05
|
|
|
B2M
|
[NCBI]
|
2.35783e-05
|
|
|
ALB
|
[NCBI]
|
2.24224e-05
|
|
|
LCN2
|
[NCBI]
|
2.16742e-05
|
|
|
ADORA1
|
[NCBI]
|
1.91786e-05
|
|
|
AQP1
|
[NCBI]
|
1.84171e-05
|
|
|
CLDN16
|
[NCBI]
|
1.77941e-05
|
|
|
PTPRO
|
[NCBI]
|
1.721e-05
|
|
|
PTHLH
|
[NCBI]
|
1.67014e-05
|
|
|
ACE
|
[NCBI]
|
1.63325e-05
|
|
|
GALNT3
|
[NCBI]
|
1.61956e-05
|
|
|
KCNJ1
|
[NCBI]
|
1.57493e-05
|
|
|
INVS
|
[NCBI]
|
1.49506e-05
|
|
|
SLC22A8
|
[NCBI]
|
1.42519e-05
|
|
|
LMX1B
|
[NCBI]
|
1.36316e-05
|
|
|
CA2
|
[NCBI]
|
1.33457e-05
|
|
|
PRL
|
[NCBI]
|
1.321e-05
|
|
|
APOE
|
[NCBI]
|
1.28944e-05
|
|
|
MPO
|
[NCBI]
|
1.28757e-05
|
|
|
COL4A3
|
[NCBI]
|
1.16803e-05
|
|
|
GAS
|
[NCBI]
|
1.14796e-05
|
|
|
CAV1
|
[NCBI]
|
1.10996e-05
|
|
|
PHEX
|
[NCBI]
|
9.95281e-06
|
|
|
glycogen storage disease i
|
[NCBI]
|
9.80802e-06
|
|
|
NPY
|
[NCBI]
|
8.84715e-06
|
|
|
VIP
|
[NCBI]
|
8.80136e-06
|
|
|
FGF23
|
[NCBI]
|
8.33527e-06
|
|
|
CTGF
|
[NCBI]
|
7.6202e-06
|
|
|
AQP2
|
[NCBI]
|
6.51409e-06
|
|
|
UGB
|
[NCBI]
|
5.97742e-06
|
|
|
MTR
|
[NCBI]
|
5.79242e-06
|
|
|
ABCC2
|
[NCBI]
|
5.02497e-06
|
|
|
PCNA
|
[NCBI]
|
4.93288e-06
|
|
|
FPGS
|
[NCBI]
|
4.87821e-06
|
|
|
PTGS2
|
[NCBI]
|
4.78339e-06
|
|
|
EGF
|
[NCBI]
|
4.52397e-06
|
|
|
CALCRL
|
[NCBI]
|
4.34228e-06
|
|
|
CFH
|
[NCBI]
|
3.91225e-06
|
|
|
TS
|
[NCBI]
|
3.7807e-06
|
|
|
BGLAP
|
[NCBI]
|
3.04567e-06
|
|
|
RA
|
[NCBI]
|
2.98009e-06
|
|
|
CASR
|
[NCBI]
|
2.70294e-06
|
|
|
ABP1
|
[NCBI]
|
2.558e-06
|
|
|
CF
|
[NCBI]
|
2.17323e-06
|
|
|
GDNF
|
[NCBI]
|
1.59492e-06
|
|
|
ILK
|
[NCBI]
|
1.52631e-06
|
|
|
SHBG
|
[NCBI]
|
1.37301e-06
|
|
|
COMT
|
[NCBI]
|
8.06112e-07
|
|
|
TF
|
[NCBI]
|
7.00002e-07
|
|
|
XDH
|
[NCBI]
|
6.42151e-07
|
|
|
TTR
|
[NCBI]
|
5.79987e-07
|
|
|
CAT
|
[NCBI]
|
5.51046e-07
|
|
|
HGF
|
[NCBI]
|
1.1036e-07
|
|
|
ACP5
|
[NCBI]
|
9.41132e-08
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
5.69562e-08
|
|
|
TYMS
|
[NCBI]
|
1.82527e-09
|
|